Table 1. Proportion of infected erythrocytes with VSAs exported to host cell compartments in clinical isolates and 3D7 at different developmental stages.
| Clinical isolates | 3D7 | Clinical isolates | 3D7 | Clinical isolates1 | 3D7 | Clinical isolates2 | 3D7 | |
| 12 h | 10.5 hpi | 24 h | 22.5 hpi | 36 h | 34.5 hpi | 48 h | 46.5 hpi | |
| Pf EMP1 | 67.5% | 5.8% | 69.4% | 19.0% | 81.1% | 71.7% | 92.3% | 84.5% |
| RIFIN-A | 50.6% | 1.0% | 68.2% | 36.7% | 73.7% | 62.9% | 74.0% | 38.0% |
| STEVOR | 5.3% | 0% | 47.9% | 34.7% | 79.4% | 91.1% | 81.0% | 38.2% |
| Pf MC-2TM | 3.0% | 0% | 7.6% | 43.9% | 18.3% | 87.9% | 20.0% | 68.9% |
1
Time point not determined for isolate #1.
2
Time point of 44 h for isolate #4.
hpi, hours post-infection.